✦ LIBER ✦

Neutropenic infections in 100 patients with non-Hodgkin’s lymphoma or Hodgkin’s disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option

✍ Scribed by Seropian, S; Nadkarni, R; Jillella, A P; Salloum, E; Burtness, B; Hu, G L; Zelterman, D; Cooper, D L

Book ID: 110010905
Publisher: Nature Publishing Group
Year: 1999
Tongue: English
Weight: 56 KB
Volume: 23
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bmt.1701610

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy with BUCY or BEAC

High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin’s lymphoma

✍ Weaver, C H; Schwartzberg, L; Rhinehart, S; West, J; Zhen, B; West, W H; Buckner 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 59 KB

Randomized trial of peripheral blood pro

Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin’s lymphoma and Hodgkin’s disease: a clinical and molecular analysis

✍ Kanteti, R; Miller, K B; McCann, J C; Roitman, D; Morelli, J; Hurley, C; Berkman 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB

High-dose chemotherapy and peripheral bl

High-dose chemotherapy and peripheral blood stem cell infusion in patients with non-Hodgkin’s lymphoma: results of outpatient treatment in community cancer centers

✍ Weaver, C H; Schwartzberg, L; Zhen, B; Mangum, M; Leff, R; Tauer, K; Rosenberg, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 168 KB

Feasibility and toxicity of high-dose ch

Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (60 years) with non-Hodgkin’s lymphoma: comparison with patients <60 years treated within the same protocol

✍ Jantunen, E; Mahlamäki, E; Nousiainen, T 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 54 KB

High-dose sequential chemotherapy and pe

High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma : A multicenter study of the Intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrence

✍ Corrado Tarella; Alessandra Cuttica; Umberto Vitolo; Marina Liberati; Massimo Di 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract ## BACKGROUND The objective of the current study was to evaluate in a multicenter setting the feasibility and efficacy of a high‐dose sequential (HDS) chemotherapy regimen that combined intensive debulking and high‐dose therapy (HDT) with peripheral blood progenitor cell (PBPC) autogra

A randomized trial of chemotherapy with

A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2)

✍ J.-P. Glossmann; A. Josting; B. Pfistner; U. Paulus; A. Engert; German Hodgkin's 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 90 KB